Billy W. Loo, Jr., MD, PhD, DABR
Academic Appointments
- Assistant Professor - Med Center Line, Radiation Oncology - Radiation Therapy
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Radiation Oncology 875 Blake Wilbur Dr MC 5847 Stanford, CA 94305 Tel Work (650) 736-7143 Fax (650) 725-8231Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Tel (650) 723-6171 Tel (650) 736-7143Administrative Contact Jackie To Clinical and Research Assistant Email Tel Work 650-736-7143Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Head and Neck Cancer
- Cancer> Radiation Oncology
- Cancer> Thoracic Oncology
- Radiation Oncology
- Radiation Therapy
- Lung Cancer
Administrative Appointments
- Co-Chair, New Technologies Committee, Radiation Oncology (2011 - present)
- Thoracic Radiation Oncology Program Leader, Radiation Oncology (2005 - present)
Honors and Awards
- Educator of the Year Award, Association of Residents in Radiation Oncology (2012)
- Henry S. Kaplan Memorial Prize for Teaching in Radiation Oncology, Stanford University (2009)
- Young Investigator Travel Grant, ECOG (2005)
- Basic Science Travel Grant, ASTRO (2005)
- Roentgen Resident/Fellow Research Award, RSNA (2004)
- Travel Grant Award, Best of ASCO Meeting, Denver, ASCO (2004)
Professional Education
| Board Certification: | Radiation Oncology, American Board of Radiology (2006) |
| Residency: | Stanford University Medical Center CA (2005) |
| Internship: | Kaiser Foundation Hospital Program CA (2001) |
| Ph.D.: | U.C.S.F., U.C. Berkeley, Bioengineering (2000) |
| Medical Education: | UC Davis School of Medicine CA (2000) |
| A.B.: | U.C. Berkeley, Biophysics (1989) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
My main clinical specialties are radiation treatment of lung cancer and head & neck cancer, and I serve as the Thoracic Radiation Oncology Program Leader.
My clinical research interests include 4-D multimodality imaging of tumor and organ motion using CT, PET, and MR; novel functional/metabolic imaging of tumor hypoxia and lymphatic drainage; and implementation and clinical trials of high-precision image-guided radiation therapy including 4-D IMRT, dynamic conformal arc radiotherapy (DCART) and volumetric modulated arc therapy (VMAT), and stereotactic ablative radiotherapy (SABR). My preclinical and translational research interests include novel functional imaging of inflammation as a mechanism of late normal tissue radiation injury, novel reconstruction and processing methods for 4-D imaging data to reduce artifacts and extract functional/physiologic information, and the radiobiology of tumor hypoxia and SABR.
Clinical Trials
- Recruiting BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Not Recruiting A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
- Recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
- Recruiting Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
- Recruiting Imaging and Biomarkers of Hypoxia in Solid Tumors
Publications
- Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med. 2013; (1): 27-32
- Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. J Appl Clin Med Phys. 2013; (2): 4046
- Non-Small Cell Lung Cancer, Version 2.2013. J Natl Compr Canc Netw. 2013; (6): 645-653
- Radiotherapy for nonadenoid cystic carcinomas of major salivary glands. Am J Otolaryngol. 2013
- Small cell lung cancer. J Natl Compr Canc Netw. 2013; (1): 78-98
- The optimal use of radiotherapy in small cell lung cancer. J Natl Compr Canc Netw. 2013; (1): 107-14
